Delphine Verbeke
Aalst, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
In Vitro Model of Prepacked Carbon Dioxide Absorber Use: Development and Testing.
Journal: Anesthesiology
Published: December 13, 2023
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 15, 2020
Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia.
Journal: HemaSphere
Published: April 29, 2019
Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: September 21, 2018
Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition.
Journal: Science translational medicine
Published: June 29, 2018
Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice.
Journal: European journal of immunology
Published: March 13, 2018
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.
Journal: Cancer discovery
Published: May 24, 2017
Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: March 30, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026